Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alpha-2a + Ribavirin in HCV with Normal ALT
NCT00575627Phase 4Unknown
- Sponsor
- University of Turin
- Start
- Sep 2007
- Primary completion
- Sep 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a in hepatitis C (HCV) (2 arms), sponsored by University of Turin. Primary endpoint: Efficacy of treatment and outcome of treated patients compared with a control group. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00575627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575627.